CJC-1295 No DAC + Ipamorelin - 5/5mg Blend

Chemical & Structural Information

• Product type: Two-peptide blend; the blend has no single CAS number or formula
• CJC-1295 No DAC: Common market name for Modified GRF(1-29), a short-acting GHRH analogue
• Modified GRF(1-29) Molecular Weight: approximately 3,367.9 g/mol; CAS numbers are used inconsistently, so the
batch COA is the best identity reference
• Ipamorelin: CAS 170851-70-4 | C38H49N9O5 | approximately 711.9 g/mol

What It Is

This blend combines two peptides that signal growth hormone release through different receptors. CJC-1295 No
DAC is used as a name for Modified GRF(1-29), which acts on the GHRH receptor. Ipamorelin acts on the ghrelin
receptor.

Research Focus

• Dual-pathway GH research - scientists study whether using two receptor pathways changes GH release.
• Pituitary signalling - both pathways send signals to the pituitary gland.
• IGF-1 - changes in GH can also affect downstream IGF-1.
• Pulse research - short-acting GHRH analogues and secretagogues are often studied in relation to natural GH pulses.

How It Is Studied

Modified GRF(1-29) activates the GHRH receptor. Ipamorelin activates GHSR. Because these are different
receptors, researchers can study how the two signals interact.

Glossary

• GHRH: The natural signal that tells the pituitary to release GH.
• GHSR: The ghrelin receptor.
• Pituitary: A small hormone-releasing gland in the brain.
• DAC: Drug Affinity Complex - a modification used to make some CJC-1295 forms last longer.

For Research Purposes Only